The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can turn ...

Biotechnology is transforming natural health products. Advanced methods improve plant extract purity and potency. This ...

MAIA Biotechnology (MAIA) announced highlights from a recent presentation at the European Society for Medical Oncology, ESMO, Congress 2025 held ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

Mary Roach encouraged the use of humor to break down barriers in medical discourse while promoting her new book “Replaceable ...

The 18,500-square-foot building offers industry-grade training for biotech technicians and is part of McCord's efforts to brand Generation Park as a premier life sciences hub in Houston.

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Doha's healthcare expenditure is slated to touch $13bn by 2030, showing a 14% compound annual growth rate (CAGR) and ...